<DOC>
	<DOCNO>NCT01365221</DOCNO>
	<brief_summary>The primary objective study compare platelet reactivity patient receive load dose clopidogrel reload dose prasugrel patient receive load dose prasugrel .</brief_summary>
	<brief_title>The Effect Reloading Prasugrel Patient Who Has Already Received Loading Dose ( LD ) Clopidogrel</brief_title>
	<detailed_description>This prospective , open-label , non-randomized trial approximately 260 patient Acute Coronary Syndrome ( ACS ) undergo percutaneous coronary intervention ( PCI ) . In order compare platelet reactivity , assess VerifyNow P2Y12 assay , plan recruit two study group interest : 1 . Patients already receive 600 mg load dose ( LD ) clopidogrel preparation PCI receive load dose 60 mg prasugrel . 2 . Patients receive LD clopidogrel receive 60 mg LD prasugrel prior PCI . A subset 40 patient study group ( 80 patient total ) undergo additional platelet reactivity test vasodilator stimulate phosphoprotein ( VASP ) assay.All patient follow throughout duration hospital stay .</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>1 . Patients age 18 old , gender 2 . Presenting ACS , define least two follow : Symptoms consistent myocardial ischemia ; ST segment elevation depression least 1 mm 2 contiguous lead EKG ; Cardiac troponin I level upper limit normal . 3 . An initial invasive strategy ( e.g . early angiography ) plan . 4 . No contraindication prasugrel therapy . 1 . Known allergy aspirin , clopidogrel , prasugrel . 2 . Patient know pregnant lactating . 3 . Patient known history bleed diathesis , currently active bleeding . 4 . Platelet count &lt; 100,000/mm3 time enrollment . 5 . Hematocrit &lt; 25 % time enrollment . 6 . On warfarin therapy time PCI , patient likely require warfarin therapy postPCI . 7 . Received fibrinolytics within past 48 hour . 8 . Received glycoprotein IIb/IIIa inhibitor within past 48 hour , strategy PCI involve glycoprotein IIb/IIIa inhibitor plan . 9 . Taking maintenance thienopyridine therapy previous 7 day . 10 . Known blood transfusion within precede 10 day . 11 . Patients treat nonsteroidal antiinflammatory drug ( NSAIDS ) within previous 5 day . 12 . Patients know chronic liver disease . 13 . Age great 75 year . 14 . Body weight less 60 kg . 15 . History stroke transient ischemic attack . 16 . Surgery plan within 1 month . 17 . Patient likely require coronary artery bypass grafting . 18 . Any significant medical condition , investigator 's opinion , may interfere patient 's optimal participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Prasugrel</keyword>
</DOC>